Cybin (HELP) Beginning Cash Balance (2020 - 2025)
Cybin's (HELP) quarterly Beginning Cash Balance came in at $83.8 million in Q4 2025, down 26.74% YoY from $114.3 million in Q4 2024, and down 29.44% on a QoQ basis from $118.7 million in Q3 2025.
Cybin (HELP) Beginning Cash Balance (2020 - 2025) Analysis & Trends
Cybin (HELP) has 6 years of Beginning Cash Balance data on file, last reported at $83.8 million in Q4 2025.
- Quarterly Beginning Cash Balance fell 26.74% year-over-year to $83.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $410.7 million (down 1.22% YoY) and the FY2023 annual result came in at $31.0 million, up 571.7% from the prior year.
- Beginning Cash Balance declined to $83.8 million in Q4 2025, from $118.7 million in the prior quarter.
- In the past five years, Beginning Cash Balance ranged from a high of $154.2 million in Q2 2024 to a low of -$9.6 million in Q1 2023.
- A 5-year average of $58.6 million and a median of $43.8 million in 2021 frame the typical range for Beginning Cash Balance.
- Annual changes were most pronounced in 2021 — Beginning Cash Balance jumped 4574.57% — and 2023, when it slumped 78.58%.
- Tracing HELP's Beginning Cash Balance over 5 years: stood at $59.6 million in 2021, then plunged by 63.02% to $22.1 million in 2022, then tumbled by 39.66% to $13.3 million in 2023, then surged by 759.0% to $114.3 million in 2024, then retreated by 26.74% to $83.8 million in 2025.
- The last three Beginning Cash Balance figures came in at $83.8 million (Q4 2025), $118.7 million (Q3 2025), and $93.9 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Cybin | 417.29 Mn | 417.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 83.75 Mn |
| Dec 31, 2025 | 83.75 Mn |
| Sep 30, 2025 | 118.69 Mn |
| Sep 30, 2025 | 118.69 Mn |
| Jun 30, 2025 | 93.92 Mn |
| Jun 30, 2025 | 93.92 Mn |
| Dec 31, 2024 | 114.32 Mn |
| Dec 31, 2024 | 114.32 Mn |
| Sep 30, 2024 | 133.90 Mn |
| Sep 30, 2024 | 133.90 Mn |
| Jun 30, 2024 | 154.24 Mn |
| Jun 30, 2024 | 154.24 Mn |
| Dec 31, 2023 | 13.31 Mn |
| Dec 31, 2023 | 13.31 Mn |
| Sep 30, 2023 | 6.97 Mn |
| Sep 30, 2023 | 6.97 Mn |
| Jun 30, 2023 | 12.38 Mn |
| Jun 30, 2023 | 12.38 Mn |
| Feb 28, 2023 | -9.63 Mn |
| Feb 28, 2023 | -9.63 Mn |